The inaugural Genetic Agency Technology Conference (GATC) on November 11th, 2025 will convene technical thought leaders, gene therapy developers, patients, their families, and patient advocates across ...
Researchers created a highly efficient gene-editing method that fixes multiple DNA mutations in a single step. The breakthrough could revolutionize genetic medicine by making treatments for complex ...
Malaria remains one of the world’s deadliest diseases. Each year malaria infections result in hundreds of thousands of deaths, with the majority of fatalities occurring in children under five. The ...
Genetic Technologies’ EasyDNA platform has over $7m in annual recurring revenues in the Paternity and Health and wellness space across global markets along with its expanding product portfolio ...
4 天on MSN
Adjustable DNA 'shield' can control timing and rate at which mRNA produces proteins in vivo
RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...
Genetic Technologies (AU:GTG) has released an update. Genetic Technologies Limited has partnered with Stayhealthy, Inc. to distribute Stayhealthy’s Multi-Risk Test across North America, marking a ...
Nearly 80% of people in Australia and the U.S. that used Genetic Technologies Ltd.’s Genetype multi-risk assessment test showed an elevated risk for at least one disease covered by the test.
Thank you for joining us, and afternoon for those joining us from the U.S. I’m really pleased to have both Simon Morriss, the Chief Executive Officer of Genetic Technologies; and Tony Di Pietro, the ...
TipRanks on MSN
Genetic Technologies Announces Change in Company Secretary
Genetic Technologies ( ($AU:GTG) ) has issued an update. Genetic Technologies Limited announced the resignation of Mr. Mark Ziirsen as the Joint ...
Genetic Technologies (NASDAQ:GENE) said Friday its June-quarter receipts were A$2.1 million. At the end of June 2023, the company had A$7.9 million in cash and cash equivalents. Cash receipts from ...
Genetic Technologies Limited, a prominent player in genomics-based diagnostics, has announced the deferral of its financial reporting obligations and Annual General Meeting due to the appointment of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果